ArriVent BioPharma reports 2026 shareholder votes
ArriVent BioPharma, Inc. reported results of its 2026 annual meeting of stockholders held via live webcast.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
ArriVent BioPharma, Inc. reported results of its 2026 annual meeting of stockholders held via live webcast. Stockholders elected three Class II directors—James Healy, M.D., Ph.D., John Hohneker, M.D., and Stuart Lutzker, M.D., Ph.D.—to serve until the 2029 annual meeting.
Of 46,368,442 common shares eligible to vote as of April 21, 2026, 33,418,793 shares, or 72.07%, were present or represented by proxy, satisfying quorum requirements. Stockholders also ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding eligible to vote: 46,368,442 shares
Quorum shares represented: 33,418,793 shares (72.07%)
Votes for James Healy: 18,058,285 shares
+3 more
6 metrics
Shares outstanding eligible to vote
46,368,442 shares
Common stock eligible as of April 21, 2026 record date
Quorum shares represented
33,418,793 shares (72.07%)
Shares present or by proxy at 2026 annual meeting
Votes for James Healy
18,058,285 shares
Election of Class II director at 2026 annual meeting
Votes for John Hohneker
28,043,164 shares
Election of Class II director at 2026 annual meeting
Votes for Stuart Lutzker
29,495,923 shares
Election of Class II director at 2026 annual meeting
Votes for auditor ratification
33,411,773 shares
Ratification of PwC as auditor for fiscal year 2026
Key Terms
quorum, broker non-votes, independent registered public accounting firm, Emerging Growth Company, +1 more
5 terms
quorum financial
"a quorum of 33,418,793 shares, or 72.07% of the eligible shares, was present"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
broker non-votes financial
"the number of broker non-votes on each of the foregoing matters are set forth below"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Emerging Growth Company regulatory
"Emerging Growth Company x"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Annual Meeting financial
"held its 2026 annual meeting of stockholders (the “Annual Meeting”) via live audio webcast"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ArriVent BioPharma stockholders approve at the 2026 annual meeting?
Stockholders elected three Class II directors and ratified PricewaterhouseCoopers LLP as independent auditor for 2026. These actions confirm the company’s proposed board composition and its choice of audit firm for the fiscal year ending December 31, 2026.
What quorum was achieved at ArriVent BioPharma’s 2026 annual meeting?
The meeting reached a quorum with 33,418,793 shares present or represented by proxy, equal to 72.07% of eligible shares. Achieving this quorum allowed all director elections and auditor ratification proposals to be validly considered and approved by stockholders.
How did ArriVent BioPharma stockholders vote on the 2026 director nominees?
James Healy received 18,058,285 votes for and 11,527,650 withheld, with 3,832,858 broker non-votes. John Hohneker received 28,043,164 votes for and 1,542,771 withheld. Stuart Lutzker received 29,495,923 votes for and 90,012 withheld, each with 3,832,858 broker non-votes.
What were the vote totals for ratifying ArriVent BioPharma’s independent auditor?
For auditor ratification, 33,411,773 shares voted for PricewaterhouseCoopers LLP, 829 voted against, and 6,191 abstained, with zero broker non-votes. This strong approval confirms PwC as independent registered public accounting firm for the fiscal year ending December 31, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates